Top 5 Innovators to Watch in 2024
House Committee Passes Key Legislations Clearing the Path for Congressional Action
Significant legislative progress related to healthcare innovation and human-relevant testing has been underway on Capitol Hill. On May 11, 2022, The House Energy and Commerce Health Subcommittee passed H.R. 7667, the Food and Drug Amendments of 2022. This step paved the way for comments and markup at the full committee meeting, which occurred on May 18, […]
CCS’s co-written opinion piece published in The Hill prompts a thoughtful thank you letter from Congresswoman Anna Eshoo
The creation of a $6.5 billion Advanced Research Projects Agency for Health, also known as ARPA-H, is a new initiative proposed by President Biden in his full budget request to Congress for Fiscal Year 2022. ARPA-H is to be modeled after the similarly named Defense Advanced Research Projects Agency (DARPA). The goal of ARPA-H is […]
A Student’s Perspective on Human-Relevant Testing Models
Debating animal research was never a particularly central topic throughout my short life so far as a university student. There are the occasional animal activist campaigns about how companies need to stop using them to test cosmetics or drugs, and how ‘Mouse Lives Matter Too!’ I remember the flyers being passed around in the lecture theatres, the posters dotted around […]
Student Corner: Questions with Dr. Kristen O’Halloran Cardinal
CCS Intern, Syama Patel, and Fellow, Mikalah Singer had a virtual “sit-down” with Dr. Kristen O’Halloran Cardinal from California Polytechnic State University. Dr. O’Halloran Cardinal holds a Ph.D. in Biomedical Engineering from the University of Arizona where her research focused on tissue engineered blood vessels and intravascular device evaluation. Kristen’s research lab at Cal Poly […]
“Minimizing Animal Models”: Fireside Chat with the Terasaki Institute for Biomedical Innovation
The Terasaki Institute for Biomedical Innovation, based in Los Angeles, California, is a multi-disciplinary biomedical research establishment. Focusing on technologies such as microfluidics, organ-on-a-chip, and tissue engineering, researchers at the institute conduct cutting edge scientific research to develop superior, more physiologically relevant disease models and platforms for the testing of new human drugs. Often, their […]
Panel Discussion at ACTC Conference
Notes from The Field “Good science is not enough to persuade people to replace animal testing” – Round Table at Advances in Cell and Tissue Culture (ACTC) Conference, UK, October 2020. Jarrod Bailey, Ph.D. – Director of Science and Technology, Center for Contemporary Sciences The ACTC conference has taken place in the UK for each of the […]
MSU Researchers Developed the First Functioning Mini Human Heart Model
MSU researchers have developed the first functioning mini human heart model—a major step in human-relevant biology models Author: Mikalah Singer, JD, CCS Fellow Researchers at Michigan State University (MSU) have grown the first functioning mini human heart model. As discussed in a recently published study, the model includes all the primary heart cell types, as […]